Navigation Links
Researcher develops screening tool to identify patients with prediabetes
Date:12/4/2008

COLUMBIA, Mo. A third of Americans with diabetes do not know that they have it, and many more who have prediabetic conditions are unaware that they are at risk. A University of Missouri researcher has created a clinical tool to identify those at highest risk for having undetected hyperglycemia, impaired fasting glucose (IFG) and undiagnosed diabetes. If these conditions are identified early, patients may benefit from preventative strategies that can minimize progression to diabetes, other diseases and mortality.

"Diabetic risk factors are not equal and assessing a combination of risk factors can be confusing," said Richelle J. Koopman, assistant professor of family and community medicine in the MU School of Medicine. "A tool that weighs the relative contributions of multiple risk factors and creates an overall risk score will help clinicians decide which patients to screen for diabetes. The tool we have developed is easy to use and the screening can be done with pencil and paper. Patients can do it at a health fair or a physician's office."

The Tool to Assess Likelihood of Fasting Glucose Impairment (TAG-IT) is designed to use factors that are self-reported or easily measured. The six factors include: age, sex, BMI, family history resting heart rate and measured high blood pressure.

The average age of diagnosis for diabetes in the United States is 46 years old. However, patients are likely to develop prediabetic conditions at a younger age. In the United States, 57 million people have IFG. As type 2 diabetes becomes an increasing burden in younger populations, it's important to have a screening tool that can assess undiagnosed diabetes and IFG in people as young as 20, Koopman said.

"There has been increasing evidence that prediabetic states are associated with diseases and other complications, and strategies that prevent diabetes in those with prediabetes are effective," Koopman said. "The TAG-IT tool will help phy
'/>"/>

Contact: Kelsey Jackson
JacksonKN@missouri.edu
573-882-8353
University of Missouri-Columbia
Source:Eurekalert  

Page: 1 2

Related medicine news :

1. LA BioMed researchers among Southern California Super Doctors
2. Researchers discover new enzyme in cancer growth
3. Researchers identify cell group key to Lyme disease arthritis
4. Interferon needed for cells to remember how to defeat a virus, UT Southwestern researchers report
5. MU researcher calls for increase in sexual assault awareness programs on college campuses
6. VisEn Co-Founder Named Radiologic Societys Outstanding Researcher of the Year
7. Children Tell Researchers: Well Get Fit if Its Fun
8. Researchers identify how binge drinking may drive heart disease
9. UCSD researchers identify potential new drug target for chronic leukemia
10. USC researchers identify novel approach for suppressing prostate cancer development
11. Researchers identify new leprosy bacterium
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Researcher develops screening tool to identify patients with prediabetes
Researcher develops screening tool to identify patients with prediabetes
(Date:7/3/2009)... Upstate HomeCare, a home ..., specialty medication, respiratory and DME servic... NY have opened. One specializes in home infusion ...line for Upstate HomeCare. , ...HomeCare , a home medical services provider specia...
(Date:7/2/2009)..., AfPA; HAAF Urge State Leaders to Support Princi...AMENTO, Calif., July 2 ...ealth insurance companies have too much influence ...out of five (80%) voters support the concept of a ...e a series of guiding principles for health insura...
(Date:7/2/2009)..., CHICAGO, July 2 Pro-... the Ohio Supreme Court ruled to uphold a state la...ollow FDA guidelines in administering RU-486 (also... the health of women using the drug. , , The r...allenge by Planned Parenthood to a 2004 law requir...
(Date:7/2/2009)..., PHILADELPHIA, July 2 ...in Italy per 100,000 women between the ages of 0 t...ove official estimates issued by the Ministry of H...ound in the youngest group studied (ages 25 to 44)...ation databases that track major breast surgeries ...
Breaking Medicine News(10 mins):Health News:Upstate HomeCare Expands, Adds Pharmacies 2Health News:Upstate HomeCare Expands, Adds Pharmacies 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 2Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 3Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 4Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 5Health News:4 out of 5 CA Voters Demand Health Insurer "Code of Conduct" 6Health News:Ohio Supreme Court Strikes a Blow to Planned Parenthood in Upholding Regulation of 'Abortion Pill' 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 2Health News:Rate of Breast Cancer in Italy Significantly Higher Than Previously Reported 3
...erly people living in the community and not in ass...t // depression and its symptoms have been shown t...udy, involved 250 participants in a community heal...esearchers determined the presence of depression a...
...iagnose melancholic depression using an imaging te... certain substances in the brain. Melancholia is a...somnia, loss of appetite, and loss of pleasure. Re...e inhibitory transmitter GABA and high levels of t...
... the lungs, including emphysema and chronic bronch...amage and irreversible airflow limitation. With as...ed, causing airflow obstruction and difficulty bre...t to be permanent. Plus, the symptoms of asthma ca...
...ease Control and Prevention says 30 percent of chi...tile,// and 15 percent of children have a BMI abov...last 20 years and the National Institutes of Healt...rcent chance of becoming overweight adults, which ...
Other Medicine News:
(Date:6/26/2009)... , DEERFIELD, Ill., June 26, and OSAKA, Japan, ...l Company Limited ("Takeda") today announced that ...nc., a wholly owned United States (U.S.) subsidiar...nse letter from the U.S. Food and Drug Administrat...tion (NDA) for alogliptin, a selective dipeptidyl ...
(Date:6/26/2009)... , Positive Opinion Recommends Approval of New ...Novel SmartJect(TM) Autoinjector , , HORSHAM, P...Call/ -- Centocor Ortho Biotech Inc. and Schering-...that the Committee for Medicinal Products for Huma...A) adopted a positive opinion recommending the app...
(Date:6/25/2009)... , Company Also Receives Patent Covering ARIKAC...ections , , MONMOUTH JUNCTION, N.J., June 25 /P...ics Inc., the nonprofit affiliate of the Cystic Fi...rd to Transave Inc., for the continued development...), an antibiotic that aims to treat Pseudomonas ...
(Date:6/24/2009)... , Study shows 4% CHG antiseptic is effective a..., Ga., June 24 Hand washing with a...washing product is one effective way to stop the s...s Antiseptic/Antimicrobial Skin Cleanser and Hibis...s have been tested and found to be effective again...
Breaking Medicine Technology:Takeda Receives FDA Complete Response Letter for Alogliptin, an Investigational Treatment for Type 2 Diabetes 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 2SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 3SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 4SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 5SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 6SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 7SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 8SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 9SIMPONI(TM) (golimumab) Receives Positive Opinion From CHMP for Once-Monthly Subcutaneous Treatment of Rheumatoid Arthritis, Psoriatic Arthritis and Ankylosing Spondylitis 10Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 2Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 3Transave Receives $2.2 Million Cystic Fibrosis Foundation Award for Development of ARIKACE(TM) 4Hand Washing with 4% CHG Antiseptic Kills Flu Viruses 2Plant geneticists find veritas in vino 1660 1Plant geneticists find veritas in vino 1660 2Plant geneticists find veritas in vino 1660 3Faster X ray interferometers due to single photon interference 2282 1Faster X ray interferometers due to single photon interference 2282 2TriWest Contributes 2412 000 to Alaska National Guard Fund 8508 1TriWest Contributes 2412 000 to Alaska National Guard Fund 8508 2Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica 28R 29 for 24700 Million 8505 1Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica 28R 29 for 24700 Million 8505 2Royalty Pharma Acquires a Portion of Northwestern Universitys Royalty Interest in Lyrica 28R 29 for 24700 Million 8505 3
Bard® Dermal Allograft meets the demanding requirements of most pelvic floor reconstructive procedures, and is highly resistant to suture pull-through, demonstrating long-term durability, and se
The QIAamp Viral RNA Mini Kit allows purification of viral nucleic acids from cell-free fluid samples. Examples of viral nucleic acids that can be isolated with this kit include, but are not limited
The PersonalLAB junior is an automated microplate analyzer capable of fully automating immunoenzymatic techniques using a microplate format, per the reagent manufacturer's instruction for use and spe
MAP D-Type can combine a number of assay steps for up to 180 microplates on a simple to use benchtop device. The D-Type base instrument is a multifunctional stand-alone device but also provides easy
Medicine Products: